![22-4-Repligen-Alvotech-CR-Cover-Border.png 22-4-Repligen-Alvotech-CR-Cover-Border.png](https://eu-images.contentstack.com/v3/assets/blt0a48a1f3edca9eb0/blt335f0504ce7f9d7b/66311bfcf7b6c867bb1a870f/22-4-Repligen-Alvotech-CR-Cover-Border.png?width=700&auto=webp&quality=80&disable=upscale)
UFDF is a critical step in the downstream process that commonly uses tangential flow filtration (TFF) techniques. Traditional UFDF relies on mass-balance monitoring, which presents challenges such as variability across runs and the need for frequent sampling. As the demand for high-concentration monoclonal antibody (mAb) drugs rises, there's a growing pressure to optimize processes while maintaining critical quality attributes. Process Analytical Technology (PAT) offers a solution by enabling real-time protein concentration monitoring using ultraviolet-visible (UV-vis) spectroscopy through Variable Pathlength Technology (VPT). The KrosFlo FS-15 TFF system, incorporating VPT technology, allows for proactive control based on immediate concentration feedback, enhancing process efficiency and product quality. Through experimental validation across a range of high-concentration products, this approach demonstrated significant improvements in process control, reducing errors, and ensuring consistent quality throughout downstream development.
Fill out the form below to read the full report now.